Another explanation for SM-164 effectively eliminating early BC metastasis is that it blocks interactions of cancer cells with the host microenvironment and indirectly reduces BC-enhanced OC formation by inhibiting RANKL expression by MSCs/OBs in the host organs, including bone marrow and lungs through stabilization of TRAF3 (Fig. 5). The gene discussed is TRAF3; the disease is cancer.